The Efficacy of Parent Involvement in the Treatment of Adolescent Depression

This study is currently recruiting participants.

Verified by New York State Psychiatric Institute, April 2009

First Received: April 16, 2009 No Changes Posted

Sponsors and Collaborators:	New York State Psychiatric Institute Columbia University
Information provided by:	New York State Psychiatric Institute
ClinicalTrials.gov Identifier:	NCT00883519

Purpose

The primary aim of this study is to examine whether adolescent depression and the family context in which it develops is best treated using an individual adolescent intervention or an intervention that includes both the adolescent and the parents. This will be accomplished by conducting a randomized controlled pilot study of Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) in comparison to Interpersonal Psychotherapy for Depressed Adolescents and Parents (IPT-AP).

Condition	Intervention	Phase
Major Depressive Disorder Dysthymic Disorder Depressive Disorder Not Otherwise Specified Adjustment Disorder	Behavioral: Interpersonal Psychotherapy for Depressed Adolescents Behavioral: Interpersonal Psychotherapy for Depressed Adolescents and Parents	Phase I Phase II

MedlinePlus related topics: Depression

U.S. FDA Resources

Study Type:	Interventional
Official Title:	The Efficacy of Parent Involvement in the Treatment of Adolescent Depression

Further study details as provided by New York State Psychiatric Institute:

Study Start Date:

January 2009

Arms	Assigned Interventions
IPT-A: Active Comparator	Behavioral: Interpersonal Psychotherapy for Depressed Adolescents
IPT-AP: Active Comparator	Behavioral: Interpersonal Psychotherapy for Depressed Adolescents and Parents

Eligibility

Ages Eligible for Study:	12 Years to 17 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Ages 12-17
English speaking adolescent and parent
One parent/primary caregiver willing to participate in adolescent's treatment
Meets diagnostic criteria for Major Depressive Disorder, Dysthymic Disorder, Depressive Disorder NOS, or Adjustment Disorder with Depressed Mood
BDI-II > 13
CDRS-R > 64
CGAS < 66
CBQ T score > 64

Exclusion Criteria:

Actively suicidal
Meets diagnostic criteria for substance abuse, schizophrenia, psychosis, bipolar disorder, conduct disorder, or eating disorder
mental retardation
medical illness likely to complicate or interfere with treatment
currently in active treatment for depression
currently taking medication for a psychiatric diagnosis other than ADHD

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00883519

Contacts

Contact: Meredith Gunlicks-Stoessel, Ph.D.

212-543-5812

GunlickM@childpsych.columbia.edu

Locations

United States, New York
New York State Psychiatric Institute	Recruiting
New York, New York, United States, 10032
Contact: Meredith Gunlicks-Stoessel, Ph.D. 212-543-5812 GunlickM@childpsych.columbia.edu

Sponsors and Collaborators

New York State Psychiatric Institute

Columbia University

More Information

No publications provided

Responsible Party:	Columbia University/New York State Psychiatric Institute ( Meredith Gunlicks-Stoessel, Ph.D. )
Study ID Numbers:	5758
Study First Received:	April 16, 2009
Last Updated:	April 16, 2009
ClinicalTrials.gov Identifier:	NCT00883519 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Adjustment Disorders
Depression
Mental Disorders
Mood Disorders

Dysthymic Disorder
Depressive Disorder, Major
Depressive Disorder
Behavioral Symptoms

Additional relevant MeSH terms:

Adjustment Disorders
Pathologic Processes
Disease
Depression
Mental Disorders

Mood Disorders
Depressive Disorder, Major
Dysthymic Disorder
Depressive Disorder
Behavioral Symptoms

ClinicalTrials.gov processed this record on May 06, 2009